Inflammation: TREG cell control of autoimmune inflammation: a matter of timing?
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 21037560.
- Also identified by DOI 10.1038/nrrheum.2010.155.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immunosuppression has been associated with viral reactivation in patients with chronic viral infections. a prospective study has concluded that it is safe to use anti-tumor-necrosis-factor agents in patients with chronic hepatitis B virus infection receiving antiviral prophylaxis. Is there sufficient evidence to back up this conclusion?
Medical subject headings
- Autoimmune Diseases
- Inflammation
- T-Lymphocytes, Regulatory